|
🐜
|
Influence of Erythrocyte Concentrate Storage Time on Postsurgical Morbidity in Cardiac Surgery Patients
7 auth.
S. Leal-Noval,
Irene Jara-López,
J. García-Garmendia,
A. Marín-Niebla,
Á. Herruzo-Avilés,
Pedro Camacho-Laraña,
...
J. Loscertales
|
7 |
2003 |
7
🐜
|
|
🐜
|
Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury
9 auth.
S. Leal-Noval,
M. D. Rincón-Ferrari,
A. Marín-Niebla,
A. Cayuela,
Victoria Arellano-Orden,
A. Marín-Caballos,
...
R. Amaya-Villar,
Carmen Ferrándiz-Millón,
F. Murillo-Cabeza
|
6 |
2006 |
6
🐜
|
|
🐜
|
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma
8 auth.
M. Else,
A. Marín-Niebla,
Fátima de la Cruz,
P. Batty,
E. Ríos,
C. Dearden,
...
D. Catovsky,
E. Matutes
|
6 |
2012 |
6
🐜
|
|
🐜
|
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
22 auth.
G. Iacoboni,
K. Rejeski,
G. Villacampa,
J. V. van Doesum,
A. Chiappella,
F. Bonifazi,
L. López-Corral,
M. V. van Aalderen,
M. Kwon,
N. Martínez-Cibrian,
...
S. Bramanti,
J. L. Reguera-Ortega,
Lina Camacho-Arteaga,
C. Schmidt,
A. Marín-Niebla,
M. Kersten,
A. M. Martin Garcia-Sancho,
P. Zinzani,
P. Corradini,
T. van Meerten,
M. Subklewe,
P. Barba
|
5 |
2021 |
5
🐜
|
|
🐜
|
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
29 auth.
M. Jiménez,
E. Roldán,
C. Fernández-Naval,
G. Villacampa,
M. Martínez-Gallo,
D. Medina-Gil,
S. Peralta-Garzón,
Gemma Pujadas,
Cristina Hernández,
Carlota Pagès Geli,
M. Gironella,
M. Fox,
G. Ortí,
P. Barba,
T. Pumarola,
...
A. Cabirta,
E. Catalá,
Mercedes Valentín,
A. Marín-Niebla,
A. Órfão,
Marcos González,
M. Campins,
I. Ruiz-Camps,
D. Valcárcel,
F. Bosch,
Manuel Hernández,
M. Crespo,
J. Esperalba,
P. Abrisqueta
|
5 |
2021 |
5
🐜
|
|
🐜
|
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy
14 auth.
G. Iacoboni,
M. Simó,
G. Villacampa,
E. Catalá,
C. Carpio,
C. Díaz-Lagares,
Á. Vidal-Jordana,
S. Bobillo,
A. Marín-Niebla,
A. Pérez,
...
M. Jiménez,
P. Abrisqueta,
F. Bosch,
P. Barba
|
5 |
2021 |
5
🐜
|
|
🐜
|
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
33 auth.
C. Visco,
A. Di Rocco,
A. Evangelista,
F. Quaglia,
M. Tisi,
L. Morello,
V. Zilioli,
C. Rusconi,
S. Hohaus,
R. Sciarra,
A. Re,
C. Tecchio,
A. Chiappella,
A. Marín-Niebla,
R. McCulloch,
...
G. Gini,
T. Perrone,
L. Nassi,
E. Pennese,
P. Stefani,
M. Cox,
V. Bozzoli,
A. Fabbri,
V. Polli,
S. Ferrero,
Maria Isabel Alvarez De Celis,
A. Sica,
Luca Petrucci,
L. Arcaini,
S. Rule,
M. Krampera,
U. Vitolo,
M. Balzarotti
|
5 |
2020 |
5
🐜
|
|
🐜
|
Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial
15 auth.
E. Pardal,
M. Coronado,
Alejandro Martín,
C. Grande,
A. Marín-Niebla,
C. Panizo,
J. Bello,
E. Conde,
M. Hernandez,
R. Arranz,
...
J. Bargay,
E. González-Barca,
E. Pérez-Ceballos,
S. Montes-Moreno,
M. Caballero
|
5 |
2014 |
5
🐜
|
|
🐜
|
OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE‐FIRST STUDY
30 auth.
C. Visco,
A. Rocco,
M. Tisi,
L. Morello,
A. Evangelista,
V. Zilioli,
C. Rusconi,
S. Hohaus,
R. Sciarra,
A. Re,
C. Tecchio,
A. Chiappella,
A. Marín-Niebla,
R. McCulloch,
G. Gini,
...
T. Perrone,
L. Nassi,
E. Pennese,
P. Stefani,
Maria Cristina Cox,
V. Bozzoli,
A. Fabbri,
V. Polli,
Simone Ferrero,
I. A. D. Celis,
A. Sica,
L. Arcaini,
M. Balzarotti,
S. Rule,
U. Vitolo
|
5 |
2019 |
5
🐜
|
